HomeInsightsMarket Capitalization

Market Capitalization of Glenmark Pharmaceuticals Ltd

Market Capitalization of Glenmark Pharmaceuticals Ltd

stocks purchased

₹ 1.4 Cr

Volume transacted

stocks purchased

8.4 K

stocks traded

Last Updated time: 05 Nov 12:16 PM

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

MARKETCAP

47976.22 crore

Last updated on: Nov 04, 2024

Key Highlights

  • The Market Cap of Glenmark Pharmaceuticals Ltd is ₹ 47976 crore as of 04 Nov 24.
  • The Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 18215 crore on March 2019 to ₹ 27019 crore on March 2024 . This represents a CAGR of 6.79% over 6 years. .
  • The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 1687 as of 05 Nov 12:10.

Historical Market Cap of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Glenmark Pharmaceuticals Ltd

No data available

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

PRICE

1687.6

-12.55 (-0.74%)

stock direction

Last updated on: Nov 05 12:10 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20241700.15
01 Nov 20241690.95
31 Oct 20241693.3
30 Oct 20241670.9
29 Oct 20241673.95
28 Oct 20241714.5
25 Oct 20241663.75
24 Oct 20241673.2
23 Oct 20241684.75
22 Oct 20241683.2

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Glenmark Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Glenmark Pharmaceuticals Ltd

No data available

Historical P/E Ratio of Glenmark Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Glenmark Pharmaceuticals Ltd

No data available

* All values are in %

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.
  • The company has 14 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland.

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals declare Quarterly Result

Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1...

Read more

31 Oct 202412:07

News

Glenmark Pharmaceuticals Ltd spurts 2.21%

Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...

Read more

08 Oct 202413:05

News

Glenmark Pharma spurts as Maharashtra facility clears USFDA inspection

The inspection was conducted from 9 September to 20 September 2024. In conclusion, the US ...

Read more

23 Sep 202410:12

News

Glenmark Pharma successful concludes USFDA inspection of its Aurangabad unit

Glenmark Pharmaceuticals announced that the United States Food & Drug Administration (USFD...

Read more

21 Sep 202412:53

News

Glenmark Pharma's Maharashtra facility clears USFDA inspection

The inspection was conducted from 9 September to 20 September 2024. In conclusion, the USF...

Read more

21 Sep 202416:30

News

Glenmark Pharmaceuticals to convene AGM

Glenmark Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wi...

Read more

31 Aug 202416:40

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Glenmark Pharmaceuticals Ltd Market Cap

What is the market cap of Glenmark Pharmaceuticals Ltd?

As of November 5, 2024, Glenmark Pharmaceuticals Ltd has a market capitalization of ₹47976.22, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Glenmark Pharmaceuticals Ltd's market capitalization?

Glenmark Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Glenmark Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Glenmark Pharmaceuticals Ltd's market capitalization change?

Glenmark Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*